However, such information can help clarify the sensitivity of gastric cancer cells to FOXO3-mediated growth suppression, which may aid in establishing a therapeutic strategy using PI3K-AKT inhibitors or other compounds that induce the nuclear accumulation or activation of FOXO3. This evidence concerns the gene AKT1 and gastric cancer.